Viral vectors controlled by a gene switch

Details for Australian Patent Application No. 2004297412 (hide)

Owner HSF, Pharmaceuticals, S.A.

Inventors Voellmy, Richard

Agent Davies Collison Cave

Pub. Number AU-B-2004297412

PCT Pub. Number WO2005/056806

Priority 10/731,961 10.12.03 US

Filing date 8 December 2004

Wipo publication date 23 June 2005

Acceptance publication date 26 February 2009

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/056806 Priority application(s): WO2005/056806

26 February 2009 Application Accepted

  Published as AU-B-2004297412

25 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004297414-Targeted gene delivery to nonphagocytic mammalian cells via bacterially derived intact minicells

2004297410-Compression system with multiple inlet streams